Cargando…

Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application

Background: During the last two years, a variety of assays for the serological detection of antibodies to the new SARS-CoV-2 virus have been launched and used as part of standard care in many laboratories. The pace with which these tests have been introduced into routine care emphasizes the importan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kittel, Maximilian, Eichner, Romy, Aida, Sihem, Bode, Anna, Ast, Volker, Kessler, Anja, Neumaier, Michael, Wölfel, Roman, Haselmann, Verena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412523/ https://www.ncbi.nlm.nih.gov/pubmed/36016287 http://dx.doi.org/10.3390/v14081662

Ejemplares similares

Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
por: Ast, Volker, et al.
Publicado: (2021)

Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
por: Haselmann, Verena, et al.
Publicado: (2020)

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection
por: Gerhards, Catharina, et al.
Publicado: (2021)

Interpretation of EQA results and EQA-based trouble shooting
por: Kristensen, Gunn Berit Berge, et al.
Publicado: (2017)

Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines
por: Gerhards, Catharina, et al.
Publicado: (2023)

Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome
por: Gerhards, Catharina, et al.
Publicado: (2023)

Estimating the parasitaemia of Plasmodium falciparum: experience from a national EQA scheme
por: Manser, Monika, et al.
Publicado: (2013)

First Results of an External Quality Assessment (EQA) Scheme for Molecular, Serological and Antigenic Diagnostic Test for SARS-CoV-2 Detection in Lombardy Region (Northern Italy), 2020–2022
por: Pasotti, Fabio, et al.
Publicado: (2022)

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
por: Moerman, Alena, et al.
Publicado: (2022)

Demystifying EQA statistics and reports
por: Coucke, Wim, et al.
Publicado: (2017)

EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing
por: Tong, Qing, et al.
Publicado: (2021)

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021)

Clinical pearls and pitfalls of SARS-CoV-2 serology
por: Lippi, Giuseppe, et al.
Publicado: (2023)

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016–2018
por: Donoso Mantke, Oliver, et al.
Publicado: (2018)

SARS-CoV-2 antibody testing—questions to be asked
por: Özçürümez, Mustafa K., et al.
Publicado: (2020)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Inter-Laboratory Comparisons and EQA in the Mediterranean Area
por: Haliassos, Alexander
Publicado: (2018)

The challenge of producing an EQA for the COVID-19 pandemic
por: Badrick, Tony, et al.
Publicado: (2020)

Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay
por: Kittel, Maximilian, et al.
Publicado: (2021)

Plasma-based S100B testing for management of traumatic brain injury in emergency setting
por: Haselmann, Verena, et al.
Publicado: (2021)

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
por: Keppens, Cleo, et al.
Publicado: (2021)

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Clinical evaluation of commercial automated SARS-CoV-2 immunoassays
por: Kittel, Maximilian, et al.
Publicado: (2021)

Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
por: Jurmeister, Philipp, et al.
Publicado: (2021)

The role of EQA in harmonization in laboratory medicine – a global effort
por: Jones, Graham R.D.
Publicado: (2017)

Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients
por: Gerhards, Catharina, et al.
Publicado: (2023)

SARS-CoV-2 Serology Testing in an Asymptomatic, At-Risk Population: Methods, Results, Pitfalls
por: Heyming, Theodore, et al.
Publicado: (2021)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
por: Patton, S, et al.
Publicado: (2014)

Serological assays for emerging coronaviruses: Challenges and pitfalls
por: Meyer, Benjamin, et al.
Publicado: (2014)

District level external quality assurance (EQA) of malaria microscopy in Pakistan: pilot implementation and feasibility
por: Khan, Muhammad Amir, et al.
Publicado: (2011)

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
por: Emile, Jean-François, et al.
Publicado: (2013)

Standardization in laboratory medicine: Two years’ experience from category 1 EQA programs in Spain
por: Ricós, Carmen, et al.
Publicado: (2018)

Survey material choices in haematology EQA: a confounding factor in automated counting performance assessment
por: De la Salle, Barbara
Publicado: (2017)

External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany
por: Selb, Regina, et al.
Publicado: (2020)

Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
por: Keppens, Cleo, et al.
Publicado: (2020)

Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
por: Huseynov, Aydin, et al.
Publicado: (2020)

Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
por: Kwon, Young Nam, et al.
Publicado: (2022)

Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
por: Haselmann, Verena, et al.
Publicado: (2022)

The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmes
por: Boeras, Debrah I., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_heeqhj3ine3hpmum0fn8d01qsv